SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yang Jiang, Haiqing Huang, Erin Abner, Lucas S. Broster, Gregory A. Jicha, Frederick A. Schmitt, Richard Kryscio, Anders Andersen, David Powell, Linda Van Eldik, Brian T. Gold, Peter T. Nelson, Charles Smith, Mingzhou Ding, Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States, Frontiers in Aging Neuroscience, 2016, 8,

    CrossRef

  2. 2
    Shorena Janelidze, Henrik Zetterberg, Niklas Mattsson, Sebastian Palmqvist, Hugo Vanderstichele, Olof Lindberg, Danielle Westen, Erik Stomrud, Lennart Minthon, Kaj Blennow, Oskar Hansson, CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease, Annals of Clinical and Translational Neurology, 2016, 3, 1
  3. 3
    William Jagust, Is amyloid-β harmful to the brain? Insights from human imaging studies, Brain, 2016, 139, 1, 23

    CrossRef

  4. 4
    M. Marnane, O. O. Al-Jawadi, S. Mortazavi, K. J. Pogorzelec, B. W. Wang, H. H. Feldman, G.-Y. R. Hsiung, Periventricular hyperintensities are associated with elevated cerebral amyloid, Neurology, 2016, 86, 6, 535

    CrossRef

  5. 5
    Sepideh Shokouhi, John W. Mckay, Suzanne L. Baker, Hakmook Kang, Aaron B. Brill, Harry E. Gwirtsman, William R. Riddle, Daniel O. Claassen, Baxter P. Rogers, Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment, Alzheimer's Research & Therapy, 2016, 8, 1

    CrossRef

  6. 6
    M. D. Zwan, J. O. Rinne, S. G. Hasselbalch, A. Nordberg, A. Lleo, S.-K. Herukka, H. Soininen, I. Law, J. M. C. Bahl, S. F. Carter, J. Fortea, R. Blesa, C. E. Teunissen, F. H. Bouwman, B. N. M. van Berckel, P. J. Visser, Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study, Neurology, 2016, 86, 1, 50

    CrossRef

  7. 7
    Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Jesse Cedarbaum, Robert C. Green, Danielle Harvey, Clifford R. Jack, William Jagust, Johan Luthman, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Leslie Shaw, Li Shen, Adam Schwarz, Arthur W. Toga, John Q. Trojanowski, 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, Alzheimer's & Dementia, 2015, 11, 6, e1

    CrossRef

  8. 8
    Jon B. Toledo, Henrik Zetterberg, Argonde C. van Harten, Lidia Glodzik, Pablo Martinez-Lage, Luisella Bocchio-Chiavetto, Lorena Rami, Oskar Hansson, Reisa Sperling, Sebastiaan Engelborghs, Ricardo S. Osorio, Hugo Vanderstichele, Manu Vandijck, Harald Hampel, Stefan Teipl, Abhay Moghekar, Marilyn Albert, William T. Hu, Jose A. Monge Argilés, Ana Gorostidi, Charlotte E. Teunissen, Peter P. De Deyn, Bradley T. Hyman, Jose L. Molinuevo, Giovanni B. Frisoni, Gurutz Linazasoro, Mony J. de Leon, Wiesje M. van der Flier, Philip Scheltens, Kaj Blennow, Leslie M. Shaw, John Q. Trojanowski, Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects, Brain, 2015, 138, 9, 2701

    CrossRef

  9. 9
    Qiao-Xin Li, Victor L. Villemagne, James D. Doecke, Alan Rembach, Shannon Sarros, Shiji Varghese, Amelia McGlade, Katrina M. Laughton, Kelly K. Pertile, Christopher J. Fowler, Rebecca L. Rumble, Brett O. Trounson, Kevin Taddei, Stephanie R. Rainey-Smith, Simon M. Laws, Joanne S. Robertson, Lisbeth A. Evered, Brendan Silbert, Kathryn A. Ellis, Christopher C. Rowe, S. Lance Macaulay, David Darby, Ralph N. Martins, David Ames, Colin L. Masters, Steven Collins, Alzheimer’s Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study, Journal of Alzheimer's Disease, 2015, 48, 1, 175

    CrossRef

  10. 10
    Andreas Soejitno, Anastasia Tjan, Thomas Eko Purwata, Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials, CNS Drugs, 2015, 29, 6, 487

    CrossRef

  11. 11
    Kaj Blennow, Niklas Mattsson, Michael Schöll, Oskar Hansson, Henrik Zetterberg, Amyloid biomarkers in Alzheimer's disease, Trends in Pharmacological Sciences, 2015, 36, 5, 297

    CrossRef

  12. 12
    D. Alcolea, P. Martinez-Lage, P. Sanchez-Juan, J. Olazaran, C. Antunez, A. Izagirre, M. Ecay-Torres, A. Estanga, M. Clerigue, M. C. Guisasola, D. Sanchez Ruiz, J. Marin Munoz, M. Calero, R. Blesa, J. Clarimon, M. Carmona-Iragui, E. Morenas-Rodriguez, E. Rodriguez-Rodriguez, J. L. Vazquez Higuera, J. Fortea, A. Lleo, Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease, Neurology, 2015, 85, 7, 626

    CrossRef

  13. 13
    Kaj Blennow, Bruno Dubois, Anne M. Fagan, Piotr Lewczuk, Mony J. de Leon, Harald Hampel, Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease, Alzheimer's & Dementia, 2015, 11, 1, 58

    CrossRef

  14. 14
    Els Coart, Leandro García Barrado, Flora H. Duits, Philip Scheltens, Wiesje M. van der Flier, Charlotte E. Teunissen, Saskia M. van der Vies, Tomasz Burzykowski, Henrik Zetterberg, Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer’s Disease, Journal of Alzheimer's Disease, 2015, 46, 4, 889

    CrossRef

  15. 15
    David Weise, Solveig Tiepolt, Carolin Awissus, Karl-Titus Hoffmann, Donald Lobsien, Thorsten Kaiser, Henryk Barthel, Osama Sabri, Hermann-Josef Gertz, Ralph Buchert, Critical Comparison of Different Biomarkers for Alzheimer’s Disease in a Clinical Setting, Journal of Alzheimer's Disease, 2015, 48, 2, 425

    CrossRef

  16. 16
    S. Palmqvist, H. Zetterberg, N. Mattsson, P. Johansson, L. Minthon, K. Blennow, M. Olsson, O. Hansson, Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease, Neurology, 2015, 85, 14, 1240

    CrossRef

  17. 17
    Flora H. Duits, Niels D. Prins, Afina W. Lemstra, Yolande A.L. Pijnenburg, Femke H. Bouwman, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic, Alzheimer's & Dementia, 2015, 11, 5, 523

    CrossRef

  18. 18
    Matthias L. Schroeter, Solveig Tiepolt, Anke Marschhauser, Angelika Thöne-Otto, Karl-Titus Hoffmann, Henryk Barthel, Hellmuth Obrig, Osama Sabri, Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report, BMC Neurology, 2015, 15, 1

    CrossRef

  19. 19
    Harry V. Vinters, Emerging Concepts in Alzheimer's Disease, Annual Review of Pathology: Mechanisms of Disease, 2015, 10, 1, 291

    CrossRef

  20. 20
    J. B. Toledo, M. Bjerke, K. Chen, M. Rozycki, C. R. Jack, M. W. Weiner, S. E. Arnold, E. M. Reiman, C. Davatzikos, L. M. Shaw, J. Q. Trojanowski, Memory, executive, and multidomain subtle cognitive impairment: Clinical and biomarker findings, Neurology, 2015, 85, 2, 144

    CrossRef

  21. 21
    Sidong Liu, Weidong Cai, Siqi Liu, Fan Zhang, Michael Fulham, Dagan Feng, Sonia Pujol, Ron Kikinis, Multimodal neuroimaging computing: the workflows, methods, and platforms, Brain Informatics, 2015, 2, 3, 181

    CrossRef

  22. 22
    Zhongxiao Wan, Dorrian Mah, Svetlana Simtchouk, Andreas Kluftinger, Jonathan P Little, Role of amyloid β in the induction of lipolysis and secretion of adipokines from human adipose tissue, Adipocyte, 2015, 4, 3, 212

    CrossRef

  23. 23
    Chin-Lin Huang, I-Lun Hsiao, Ho-Chen Lin, Chu-Fang Wang, Yuh-Jeen Huang, Chun-Yu Chuang, Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells, Environmental Research, 2015, 136, 253

    CrossRef

  24. 24
    Nathalie Pierrot, Renaud Lhommel, Lisa Quenon, Bernard Hanseeuw, Laurence Dricot, Christian Sindic, Jean-Marie Maloteaux, Jean-Noël Octavea, Adrian Ivanoiu, Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer’s Disease, Journal of Alzheimer's Disease, 2015, 49, 2, 271

    CrossRef

  25. 25
    Tobias Bittner, Henrik Zetterberg, Charlotte E. Teunissen, Richard E. Ostlund, Michael Militello, Ulf Andreasson, Isabelle Hubeek, David Gibson, David C. Chu, Udo Eichenlaub, Peter Heiss, Uwe Kobold, Andreas Leinenbach, Kairat Madin, Ekaterina Manuilova, Christina Rabe, Kaj Blennow, Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid, Alzheimer's & Dementia, 2015,

    CrossRef

  26. 26
    William J. Jagust, Susan M. Landau, Robert A. Koeppe, Eric M. Reiman, Kewei Chen, Chester A. Mathis, Julie C. Price, Norman L. Foster, Angela Y. Wang, The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015, Alzheimer's & Dementia, 2015, 11, 7, 757

    CrossRef

  27. 27
    Ju-Hee Kang, Magdalena Korecka, Michal J. Figurski, Jon B. Toledo, Kaj Blennow, Henrik Zetterberg, Teresa Waligorska, Magdalena Brylska, Leona Fields, Nirali Shah, Holly Soares, Robert A. Dean, Hugo Vanderstichele, Ronald C. Petersen, Paul S. Aisen, Andrew J. Saykin, Michael W. Weiner, John Q. Trojanowski, Leslie M. Shaw, The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans, Alzheimer's & Dementia, 2015, 11, 7, 772

    CrossRef

  28. 28
    Rik Ossenkoppele, Yolande A. L. Pijnenburg, David C. Perry, Brendan I. Cohn-Sheehy, Nienke M. E. Scheltens, Jacob W. Vogel, Joel H. Kramer, Annelies E. van der Vlies, Renaud La Joie, Howard J. Rosen, Wiesje M. van der Flier, Lea T. Grinberg, Annemieke J. Rozemuller, Eric J. Huang, Bart N. M. van Berckel, Bruce L. Miller, Frederik Barkhof, William J. Jagust, Philip Scheltens, William W. Seeley, Gil D. Rabinovici, The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features, Brain, 2015, 138, 9, 2732

    CrossRef

  29. 29
    Henryk Barthel, John Seibyl, Osama Sabri, The role of positron emission tomography imaging in understanding Alzheimer’s disease, Expert Review of Neurotherapeutics, 2015, 15, 4, 395

    CrossRef

  30. 30
    Martina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, Eduardo Aguera, Roberto Bernabei, Roger Bullock, Mathieu Ceccaldi, Jean-François Dartigues, Alexandre de Mendonça, Mira Didic, Maria Eriksdotter, Olivier Félician, Lutz Frölich, Hermann-Josef Gertz, Merja Hallikainen, Steen G. Hasselbalch, Lucrezia Hausner, Isabell Heuser, Frank Jessen, Roy W. Jones, Alexander Kurz, Brian Lawlor, Alberto Lleo, Pablo Martinez-Lage, Patrizia Mecocci, Shima Mehrabian, Andreas Monsch, Flavio Nobili, Agneta Nordberg, Marcel Olde Rikkert, Jean-Marc Orgogozo, Florence Pasquier, Oliver Peters, Eric Salmon, Carmen Sánchez-Castellano, Isabel Santana, Marie Sarazin, Latchezar Traykov, Magda Tsolaki, Pieter Jelle Visser, Åsa K. Wallin, Gordon Wilcock, David Wilkinson, Henrike Wolf, Görsev Yener, Dina Zekry, Giovanni B. Frisoni, The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey, Alzheimer's & Dementia, 2015, 11, 2, 195

    CrossRef

  31. 31
    Philip S.J. Weston, Ross W. Paterson, Marc Modat, Ninon Burgos, Manuel J. Cardoso, Nadia Magdalinou, Manja Lehmann, John C. Dickson, Anna Barnes, Jamshed B. Bomanji, Irfan Kayani, David M. Cash, Sebastien Ourselin, Jamie Toombs, Michael P. Lunn, Catherine J. Mummery, Jason D. Warren, Martin N. Rossor, Nick C. Fox, Henrik Zetterberg, Jonathan M. Schott, Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015, 1, 4, 440

    CrossRef

  32. 32
    A. Nordberg, Brain Mapping, 2015,

    CrossRef

  33. 33
    Antoine Leuzy, Eduardo Zimmer, Serge Gauthier, Pedro Rosa-Neto, Amyloid imaging in Alzheimer’s disease: a potential new era of personalized medicine?, Translational Neuroscience, 2014, 5, 1

    CrossRef

  34. 34
    Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, Hugo Vanderstichele, Sanna Kaisa Herukka, Niels Andreasen, Roberta Ghidoni, Piotr Lewczuk, Andreas Jeromin, Bengt Winblad, Magda Tsolaki, Barbara Mroczko, Pieter Jelle Visser, Isabel Santana, Per Svenningsson, Kaj Blennow, Dag Aarsland, José Luis Molinuevo, Henrik Zetterberg, Brit Mollenhauer, Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases, Nature Reviews Neurology, 2014, 11, 1, 41

    CrossRef

  35. 35
    Niklas Mattsson, Philip S. Insel, Susan Landau, William Jagust, Michael Donohue, Leslie M. Shaw, John Q. Trojanowski, Henrik Zetterberg, Kaj Blennow, Michael Weiner, Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease, Annals of Clinical and Translational Neurology, 2014, 1, 8
  36. 36
    David M Cash, Jonathan D Rohrer, Natalie S Ryan, Sebastien Ourselin, Nick C Fox, Imaging endpoints for clinical trials in Alzheimer’s disease, Alzheimer's Research & Therapy, 2014, 6, 9

    CrossRef

  37. 37
    Stephen N. Gomperts, Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies, Current Neurology and Neuroscience Reports, 2014, 14, 8

    CrossRef

  38. 38
    Panagiotis Alexopoulos, Laura Kriett, Bernhard Haller, Elisabeth Klupp, Katherine Gray, Timo Grimmer, Nikolaos Laskaris, Stefan Förster, Robert Perneczky, Alexander Kurz, Alexander Drzezga, Andreas Fellgiebel, Igor Yakushev, Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease, Alzheimer's & Dementia, 2014, 10, 6, 684

    CrossRef

  39. 39
    Jon B Toledo, Michael W Weiner, David A Wolk, Xiao Da, Kewei Chen, Steven E Arnold, William Jagust, Clifford Jack, Eric M Reiman, Christos Davatzikos, Leslie M Shaw, John Q Trojanowski, Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition, Acta Neuropathologica Communications, 2014, 2, 1, 26

    CrossRef

  40. 40
    Josef Pannee, Ulrika Törnqvist, Anni Westerlund, Martin Ingelsson, Lars Lannfelt, Gunnar Brinkmalm, Rita Persson, Johan Gobom, Johan Svensson, Per Johansson, Henrik Zetterberg, Kaj Blennow, Erik Portelius, The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease, Neuroscience Letters, 2014, 573, 7

    CrossRef

  41. 41
    José Luis Molinuevo, Kaj Blennow, Bruno Dubois, Sebastiaan Engelborghs, Piotr Lewczuk, Armand Perret-Liaudet, Charlotte E. Teunissen, Lucilla Parnetti, The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative, Alzheimer's & Dementia, 2014, 10, 6, 808

    CrossRef

  42. 42
    Jon B. Toledo, Sharon X. Xie, John Q. Trojanowski, Leslie M. Shaw, Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI, Acta Neuropathologica, 2013, 126, 5, 659

    CrossRef

  43. 43
    Meredith N. Braskie, Paul M. Thompson, Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings, Trends in Cognitive Sciences, 2013, 17, 10, 510

    CrossRef